FDA inspection
Belani, Chandra P., M.D.: FDA inspection ending Apr 27, 2000
FDA inspection 21057 · Voluntary Action Indicated (VAI) · Pittsburgh, PA
Key facts
| Inspection ID | 21057 |
|---|---|
| Firm | Belani, Chandra P., M.D. |
| FEI number | 3002983294 |
| Address | 200 Meyran Avenue, University of PGH Cancer Institute |
| City | Pittsburgh |
| State | PA |
| ZIP | 15213 |
| Fiscal year | 2000 |
| Inspection end date | Apr 27, 2000 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data